Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2009

View Archived Issues

Mechanisms of Destiny Pharma antibacterial candidates compared against S. aureus

Angion Biomedica discovers novel PARP inhibitors for the treatment of stroke

Nerve growth factor peptidomimetic MIM-D3 improves experimental dry eye

Besifloxacin shows high antibacterial activity against bacterial conjunctivitis in clinical trials

GSK offers Q1 report

Further in vitro and in vivo data on novel macrolide CEM-101 available

Novel T-type calcium channel blockers patented by Merck & Co. as antiepileptic agents

Daiichi Sankyo claims novel antidiabetic compounds

Sanofi-aventis discovers novel vanilloid TRPV1 receptor antagonists for the treatment of pain

Janssen claims novel PARP-1 inhibitors for cancer treatment

Akela and Nventa close merger agreement

Watson launches Gelnique for women with overactive bladder

Emisphere receives payment from MannKind following FDA acceptance of Afresa NDA

CSTP in Japan awards grants to NIBIO to study flu vaccine using Hemispherx's Ampligen

PharmAthene submits regulatory strategy to FDA for rPA anthrax vaccine SparVax

Bioniche presents update on phase III clinical program for Urocidin in bladder cancer

Roche reports positive 2-year data from LITHE study of Actemra in rheumatoid arthritis

Sanofi Pasteur receives order from HHS to initiate production of a A(H1N1) vaccine

Replikins reports results from analysis of peptide genomic sequence data for H1N1 virus

GSK receives order from HHS for A(H1N1) influenza vaccine antigen and adjuvant

Phase II study finds Nefecon reduces urine albumin in IgA nephropathy patients / News in Context

Type II calcimimetic compound ASP-7991 shows preclinical potential as antihyperparathyroidism drug

CAT-354, an anti-IL-13 human monoclonal antibody for asthma therapy deemed safe in healthy subjects

Scancell receives grant from U.K. EMDA to fund SCIB-1 DNA vaccine

Astellas launches Protopic in Europe in a new twice-weekly regimen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...